Research Article
Hospital-Acquired Acute Kidney Injury in Noncritical Care Setting: Clinical Characteristics and Outcomes
Table 3
Severity of AKI based on nephrology consultation.
| | | All patients | Nephrology consultation (n = 31) | No nephrology consultation (n = 191) | |
| | Baseline serum creatinine (SCr), μmol/L (mean (SD)) | 103.9 (50.3) | 146 (79) | 97.1 (40.3) | | | Median (IQR) | 89.5 (69–127.3) | 127 (89–175) | 86 (68–121) | <0.001 | | SCr at point of AKI detection, μmol/L (mean (SD)) | 155.8 (69.2) | 235.1 (108.1) | 142.9 (50.3) | | | Median (IQR) | 139.5 (109.8–181.5) | 214 (157–281) | 135 (105–172) | <0.001 | | Maximum SCr during admission, μmol/L (mean (SD)) | 172.6 (103.5) | 324.4 (179.8) | 147.9 (54.6) | | | Median (IQR) | 147 (113.8–197) | 268 (192–434) | 139 (108–176) | <0.001 | | KDIGO stage at time of AKI (N (%)) | | Stage 1 | 204 (91.9) | 21 (67.7) | 183 (95.8) | | | Stage 2 | 11 (5) | 5 (16.1) | 6 (3.1) | | | Stage 3 | 7 (3.2) | 5 (16.1) | 2 (1) | |
|
|
